Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2019

  1. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study

    PLoS ONE, Vol. 14, Núm. 9

2017

  1. Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience

    Journal of Viral Hepatitis, Vol. 24, Núm. 6, pp. 464-471

1996

  1. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease

    European Journal of Gastroenterology and Hepatology, Vol. 8, Núm. 3, pp. 273-277